The World Health Organization's proposed pandemic treaty and amended International Health Regulations would grant the body unprecedented authority to declare emergencies and direct national responses. Critics argue this erodes sovereignty and rewards an institution that failed badly in 2020; supporters say fragmented national responses cost millions of lives and only binding global coordination can prevent the next catastrophe. Several major nations have stalled ratification, and the debate is reshaping the future of global health governance.
The real debate over the WHO Pandemic Agreement is not whether the organization should gain authority to impose lockdowns or mandates. It never had that power, and the treaty explicitly withholds it. The actual question is whether a compliance architecture built around notification rules and voluntary benefit-sharing can correct the structural failures that shaped COVID-19 outcomes: a Global Health Security Index that ranked the United States first yet could not predict its catastrophic mortality, pharmaceutical intellectual property regimes that blocked rapid technology transfer, and a donor-dependent WHO budget that left the organization structurally unable to enforce equity during the last crisis.
The WHO Pandemic Agreement adopted in May 2025 explicitly preserves national sovereignty and imposes no coercive powers on member states, making the "power grab" framing largely a distortion — but the deeper problem it attempts to solve is real: COVID-19 cost $13.8 trillion and killed disproportionately even in wealthy, "prepared" nations, while the existing legally binding IHR framework was widely ignored with zero consequences. The central unresolved tension is whether a new agreement can generate compliance that the IHR failed to produce, with Gostin arguing stronger equity norms will shift behavior and Fidler countering that non-compliance with the IHR gives no logical basis for optimism — a disagreement about institutional theory that the agreement's lack of funded implementation plans does nothing to settle. Largely absent from mainstream debate is the Global South critique that the real failure was never too much WHO authority but too little equitable authority, a structural problem the agreement's unresolved Pathogen Access and Benefit-Sharing system and donor-dependent budget leave fundamentally intact.
Read the research →On May 20th, 2025, the World Health Assembly adopted the WHO Pandemic Agreement — a treaty years in the making, born from the wreckage of COVID-19. We've done our research on this one, and the facts are fascinating. Here's the scale of what we're dealing with: the IMF estimated COVID-19's cumulative economic damage at 13.8 trillion dollars through 2024. And the vaccine rollout that followed was staggeringly unequal — 80 percent of people in high-income countries got at least one dose, versus 10 percent in low-income countries, per data cited across multiple sources. Now a new treaty exists to prevent that from happening again. Supporters say fragmented national responses cost lives. Critics — from the Heritage Foundation to the South Centre in Geneva — argue that giving WHO more coordination power without fixing who bears the compliance costs just punishes poor states, not bad actors. So here's the question I want to put to the panel: does this agreement actually change anything, or is it architecture without foundations?